Loading...

HESTERBIO Hester Biosciences Ltd Management Changes Announcement

Hstr

HSTR

Hester Biosciences Ltd

(HESTERBIO)

2025 Announcement

Show Summary

Summary

AGM Notice Published

Compliance Confirmation

Compliance Report

Q4 FY25 Results

Financial Results Published

Earnings Call Audio

Financial Update

Secretarial Auditor Appoint...

Investor Meeting

Price Movement Clarification

Compliance Certificate

Office Relocation

Governance Filing

Earnings Call Summary

Financial Results Published

Earnings Call Update

Q3 FY25 Results

Earnings Call Announcement

GST Order Received

Postal Ballot Notice

Compliance Certificate

Office Relocation

Management Change

Credit Rating Update

Management Change

Management Change

CFO Appointment

Earnings Call Summary

CFO Resignation

Financial Results Published

Earnings Call Recording

Q2 FY25 Results

Earnings Call Scheduled

GST Audit Report

Securities Confirmation

Earnings Conference Call

Financial Results Publication

Financial Results

Newspaper Clipping

Earnings Conference Call

Confirmation Certificate

Price Movement Clarification

Compliance Report Submission

Earnings Transcript Released

Financial Results Publication

Financial Results Approval

Conference Call Intimation

Compliance Certificate

Certificate Compliance

Confirmation Certificate Su...

Compliance Certificate Subm...

Management Change

Financial Results Publication

Earnings Conference Call Re...

Financial Results

Earnings Conference Call

Confirmation Certificate

Conference Call

Quarterly Earnings Report

Earnings Conference Call

Financial Results

Conference Call Scheduled

Confirmation Certificate fo...

Financial Statements, Earni...

Financial Statements

Financial Statements

Investor Meetings

Equity, Debt, VC, Private E...

Appointment of Directors

Management Changes

Financial Statements Public...

Financial Statements - Appr...

External Links:

Data:

Hester Biosciences Ltd announced the audited financial results for Q4 and FY25 on 9 May 2025, declaring a dividend of ₹7 per equity share (70%) for FY 2024-25, pending shareholder approval, and appointed Shah & Shah Associates as Secretarial Auditors for five years.

AI Assistant

Hester Biosciences Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.